|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2.96 SEK | +0.17% |
|
-17.09% | -61.36% |
| Apr. 15 | Oncopeptides AB Secures National Reimbursement for Pepaxti in Spain | CI |
| Apr. 04 | Oncopeptides AB Provides Sales Guidance for the First Quarter of 2024 | CI |
Oncopeptides AB (publ) provided sales guidance for the first quarter of 2024. The company expected net sales to amount to SEK 5.1 million (SEK 1.1 million).
| 1st Jan change | Capi. | |
|---|---|---|
| -61.36% | 26.62M | |
| -2.45% | 103B | |
| +1.87% | 95.28B | |
| +1.46% | 22.15B | |
| -15.65% | 21.02B | |
| -8.58% | 18.15B | |
| -38.74% | 16.73B | |
| -13.01% | 16.05B | |
| +5.31% | 13.68B | |
| +34.86% | 12.17B |
ONCOPEPTIDES AB 
